217 related articles for article (PubMed ID: 1313390)
1. Neuroendocrine differentiation in human prostatic carcinoma.
di Sant'Agnese PA
Hum Pathol; 1992 Mar; 23(3):287-96. PubMed ID: 1313390
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.
di Sant'Agnese PA
Cancer; 1992 Jul; 70(1 Suppl):254-68. PubMed ID: 1350941
[TBL] [Abstract][Full Text] [Related]
3. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.
Di Sant'Agnese PA; Cockett AT
J Urol; 1994 Nov; 152(5 Pt 2):1927-31. PubMed ID: 7933249
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
di Sant'Agnese PA
Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in prostatic malignancy.
di Sant'Agnese PA; Cockett AT
Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
[TBL] [Abstract][Full Text] [Related]
6. Divergent neuroendocrine differentiation in prostatic carcinoma.
di Sant' Agnese PA
Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in prostatic carcinoma.
di Sant'Agnese PA; de Mesy Jensen KL
Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine differentiation in prostate adenocarcinoma].
Ramírez-Balderrama L; López-Briones S; Daza-Benítez L; Macías MH; López-Gaytán T; Pérez-Vázquez V
Gac Med Mex; 2013; 149(6):639-45. PubMed ID: 24276187
[TBL] [Abstract][Full Text] [Related]
9. Age-related changes in the neuroendocrine (endocrine-paracrine) cell population and the serotonin content of the guinea pig prostate.
Di Sant'Agnese PA; Davis NS; Chen M; de Mesy Jensen KL
Lab Invest; 1987 Dec; 57(6):729-36. PubMed ID: 3695416
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in prostatic carcinoma: an update.
di Sant'Agnese PA
Prostate Suppl; 1998; 8():74-9. PubMed ID: 9690666
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine cells in tumour growth of the prostate.
Abrahamsson PA
Endocr Relat Cancer; 1999 Dec; 6(4):503-19. PubMed ID: 10730904
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.
Noordzij MA; van Steenbrugge GJ; van der Kwast TH; Schröder FH
Urol Res; 1995; 22(6):333-41. PubMed ID: 7740652
[TBL] [Abstract][Full Text] [Related]
14. [Prostatic neuroendocrine cells].
Herrero M; Rodríguez A; Cejas H
Rev Fac Cien Med Univ Nac Cordoba; 2002; 59(1):91-6. PubMed ID: 12934249
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate.
Bonkhoff H; Stein U; Remberger K
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):291-4. PubMed ID: 7694424
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation and hormone-refractory prostate cancer.
Abrahamsson PA
Prostate Suppl; 1996; 6():3-8. PubMed ID: 8630226
[TBL] [Abstract][Full Text] [Related]
19. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
[TBL] [Abstract][Full Text] [Related]
20. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
Bonkhoff H; Fixemer T
Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
